High-level expression of Rad51 is an independent prognostic marker of survival in non-small-cell lung cancer patients

High-level expression of Rad51, a key factor in homologous recombination, has been observed in a variety of human malignancies. This study was aimed to evaluate Rad51 expression to serve as prognostic marker in non-small-cell lung cancer (NSCLC). A total of 383 non-small-cell lung tumours were analy...

Descripción completa

Detalles Bibliográficos
Autores principales: Qiao, G-B, Wu, Y-L, Yang, X-N, Zhong, W-Z, Xie, D, Guan, X-Y, Fischer, D, Kolberg, H-C, Kruger, S, Stuerzbecher, H-W
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2005
Materias:
Molecular Diagnostics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361489/
https://www.ncbi.nlm.nih.gov/pubmed/15956972
http://dx.doi.org/10.1038/sj.bjc.6602665

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361489/
https://www.ncbi.nlm.nih.gov/pubmed/15956972
http://dx.doi.org/10.1038/sj.bjc.6602665

Ejemplares similares